SCHEMBL8501155

SCHEMBL8501155

O=C1NC(=O)C2=C1C1CC[C@H]2C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9248536 1.00 DAO (0.30) DAO
SCHEMBL612988 1.00 DAO (0.30) DAO
SCHEMBL7717529 0.91
Trifluoromethanesulfonic Acid SCHEMBL3921811 0.80 PTGS2 (0.31)
SCHEMBL6944629 0.76 DAO (0.39) DAO
SCHEMBL2484399 0.71 DAO (0.32) DAO
SCHEMBL9231007 0.69
SCHEMBL12583840 0.69
SCHEMBL6099140 0.67
SCHEMBL11293127 0.67 MAOA (0.38) DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932391-A2 FUSOGENIC LIPOSOME COMPOSITION AND METHOD SEQUUS PHARMACEUTICALS, INC. (US) 1999-08-04 EP disclosed
WO-1998016202-A2 FUSOGENIC LIPOSOME COMPOSITION AND METHOD SEQUUS PHARMACEUTICALS, INC. (US) 1998-04-23 WO disclosed